Overview
Sino Biological is an internationally recognized reagent supplier and contract research organization specializing in recombinant protein production and antibody development. The company offers over 6,000 recombinant proteins and 13,000 antibodies, produced using its proprietary mammalian cell-based expression system for high-efficiency antigen and antibody manufacturing. Headquartered in Beijing with subsidiaries in the United States and Europe, its products support virology, infectious disease research, and applications like SARS-CoV-2 diagnostics with FDA EUA approvals.
Frequently asked questions
- What are Sino Biological's core capabilities in recombinant proteins and antibodies?
- Sino Biological specializes in recombinant protein production and antibody development using a proprietary mammalian cell-based expression system, offering 6,000+ recombinant proteins and 13,000+ antibodies independently developed and produced.
- What regulatory approvals do Sino Biological's products have?
- Many of Sino Biological's SARS-CoV-2 antibodies and antigens have received Emergency Use Authorization (EUA) from the FDA for use in rapid antigen and antibody tests.
- In which geographies does Sino Biological operate?
- Headquartered in Beijing, China, Sino Biological has subsidiaries in the United States and Europe/Germany, with products available in more than 90 countries worldwide.